Literature DB >> 21469108

c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.

Katharina Reinhard1, Magdalena Huber, Corinna Wostl, Anne Hellhund, Anne Toboldt, Elfadil Abass, Bärbel Casper, Thorsten Joeris, Christian Herr, Robert Bals, Ulrich Steinhoff, Michael Lohoff, Alexander Visekruna.   

Abstract

Recent studies demonstrated the crucial role of c-Rel in directing Treg lineage commitment and its involvement in T helper 1 (Th1) cell-mediated autoimmune inflammation. We thus wondered whether these opposite functions of c-Rel influence the course of antiparasitic immune responses against Leishmania major, an accepted model for the impact of T-cell subsets on disease outcome. Here we show that c-Rel-deficient (rel(-/-) ) mice infected with L. major displayed dramatically exacerbated leishmaniasis and enhanced parasite burdens. In contrast to WT mice, IFN-γ and IL-17 production in response to L. major antigens was severely impaired in rel(-/-) mice. Reconstitution of Rag1(-/-) T-cell deficient mice with rel(-/-) CD4(+) T cells followed by L. major infection demonstrated that c-Rel-deficient T cells mount normal Th1 responses and are able to contain the infection. Similarly, Th1 differentiation of naïve CD4(+) cells in vitro was normal. Notably, a selective defect in IL-12 and IL-23 production was observed in rel(-/-) DCs compared with their WT counterparts. In conclusion, our data suggest that the expression of c-Rel in myeloid cells is essential for clearance of L. major and that this c-Rel-mediated effect is dominant over the lack of Tregs.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469108     DOI: 10.1002/eji.201041056

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis.

Authors:  Ugo Fiocco; Benedetta Accordi; Veronica Martini; Francesca Oliviero; Monica Facco; Anna Cabrelle; Lucia Piva; Beatrice Molena; Francesco Caso; Luisa Costa; Anna Scanu; Elisa Pagnin; Mariangela Atteno; Raffaele Scarpa; Giuseppe Basso; Gianpietro Semenzato; Leonardo Punzi; Andrea Doria; Jean-Michel Dayer
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 2.  Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis.

Authors:  Amrita Saha; Souravi Roy; Anindita Ukil
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

3.  A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Authors:  Yusuke Shono; Andrea Z Tuckett; Samedy Ouk; Hsiou-Chi Liou; Grégoire Altan-Bonnet; Jennifer J Tsai; Jennifer E Oyler; Odette M Smith; Mallory L West; Natalie V Singer; Ekaterina Doubrovina; Dmitry Pankov; Chandresh V Undhad; George F Murphy; Cecilia Lezcano; Chen Liu; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Discov       Date:  2014-02-18       Impact factor: 39.397

4.  Characterization of promoter of the tuberculosis-resistant gene intracellular pathogen resistance 1.

Authors:  Yongyan Wu; Fayang Liu; Yan Zhang; Yongsheng Wang; Zekun Guo; Yong Zhang
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

5.  c-Rel Is a Myeloid Checkpoint for Cancer Immunotherapy.

Authors:  Ting Li; Xinyuan Li; Ali Zamani; Wei Wang; Chin-Nien Lee; Mingyue Li; George Luo; Emily Eiler; Honghong Sun; Sankar Ghosh; Jian Jin; Ramachandran Murali; Qingguo Ruan; Weiyun Shi; Youhai H Chen
Journal:  Nat Cancer       Date:  2020-05-18

Review 6.  A key role for NF-κB transcription factor c-Rel in T-lymphocyte-differentiation and effector functions.

Authors:  Alexander Visekruna; Anton Volkov; Ulrich Steinhoff
Journal:  Clin Dev Immunol       Date:  2012-03-06

7.  Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.

Authors:  Eva Ellinghaus; Philip E Stuart; David Ellinghaus; Rajan P Nair; Sophie Debrus; John V Raelson; Majid Belouchi; Trilokraj Tejasvi; Yanming Li; Lam C Tsoi; Anna T Onken; Tonu Esko; Andres Metspalu; Proton Rahman; Dafna D Gladman; Anne M Bowcock; Cynthia Helms; Gerald G Krueger; Sulev Koks; Külli Kingo; Christian Gieger; H Erich Wichmann; Ulrich Mrowietz; Stephan Weidinger; Stefan Schreiber; Gonçalo R Abecasis; James T Elder; Michael Weichenthal; Andre Franke
Journal:  J Invest Dermatol       Date:  2011-12-15       Impact factor: 8.551

8.  Protective immunity and vaccination against cutaneous leishmaniasis.

Authors:  Ifeoma Okwor; Zhirong Mou; Dong Liu; Jude Uzonna
Journal:  Front Immunol       Date:  2012-05-29       Impact factor: 7.561

9.  Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.

Authors:  Katharina M Jeltsch; Desheng Hu; Sven Brenner; Jessica Zöller; Gitta A Heinz; Daniel Nagel; Katharina U Vogel; Nina Rehage; Sebastian C Warth; Stephanie L Edelmann; Renee Gloury; Nina Martin; Claudia Lohs; Maciej Lech; Jenny E Stehklein; Arie Geerlof; Elisabeth Kremmer; Achim Weber; Hans-Joachim Anders; Ingo Schmitz; Marc Schmidt-Supprian; Mingui Fu; Helmut Holtmann; Daniel Krappmann; Jürgen Ruland; Axel Kallies; Mathias Heikenwalder; Vigo Heissmeyer
Journal:  Nat Immunol       Date:  2014-10-05       Impact factor: 25.606

10.  Functional imaging of Rel expression in inflammatory processes using bioluminescence imaging system in transgenic mice.

Authors:  Xingyu Yang; Hua Jing; Kai Zhao; Ruilin Sun; Zhenze Liu; Yue Ying; Lei Ci; Ying Kuang; Fang Huang; Zhugang Wang; Jian Fei
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.